Synthesis and characterization of amoxicillin derived silver nanoparticles: Its catalytic effect on degradation of some pharmaceutical antibiotics
Creators
- 1. Department of Chemistry, Fatih University, Buyukcekmece, 34500 Istanbul (Turkey)
- 2. National Center of Excellence in Analytical Chemistry, University of Sindh Jamshoro, Jamshoro 76080 (Pakistan)
- 3. Department of Biology, Fatih University, Buyukcekmece, 34500 Istanbul (Turkey)
Description
Graphical abstract: - Highlights: • Amp-Ag (0) NPs were prepared by simple one-pot chemical reduction method. • Ampicillin as an antibiotic was used as both reducing and capping agents in this study. • Amp-Ag (0) NPs have proved as the remarkably efficient catalysts with enhanced rate of reduction for cefdinir, cefditoren, cefixime, ceftriaxone sodium and doxycycline. • Amp-Ag (0) NPs were showed excellent catalytic activity as catalyst for the 100% reduction of these antibiotics. - Abstract: We synthesized novel amoxicillin derived silver nanoparticles (Amp-Ag (0) NPs) in aqueous solution by one-pot simple synthetic method by reducing silver nitrate by the help of amoxicillin antibiotic as a reducing/capping agent and NaOH as the catalyst for reaction enhancement. The formation of the Amp-Ag (0) NPs was monitored using UV–Vis absorption spectroscopy which confirmed the formation of Amp-Ag (0) NPs by exciting the typical surface plasmon absorption maxima at 404 nm. Transmission electron microscopy (TEM) confirmed the spherical morphology and monodispersed Amp-Ag (0) NPs with particle size 6.87 ± 2.2 nm. The antibacterial activities of the antibiotics were evaluated against Gram-negative bacteria Escherichia coli, Salmonella enteritidis, Pseudomonas aeruginosa and Gram-positive bacteria Streptococcus pneumonia, Streptococcus pyogenes, Staphylococcus aureus by the disk diffusion method. Whereas standard antibiotics showed normal zone of inhibition, the reduced ones with Amp-Ag (0) NPs showed no inhibition zone. The antimicrobial results therefore reveal that newly synthesized Amp-Ag (0) NPs had an excellent catalytic activity as catalyst for the 100% reduction of antibiotics i.e. cefdinir, cefditoren, cefiximee, ceftriaxone sodium and doxycycline, which was carried out in just 2–5 min. They were recovered easily from reaction medium and reused with enhanced catalytic potential five times. Based upon these results it has been concluded that Amp-Ag (0) NPs are novel, rapid, and highly cost-effective for environmental safety against pollution by antibiotics in wastewater and extendable for control of other reducible contaminants as well
Availability note (English)
Available from http://dx.doi.org/10.1016/j.apsusc.2014.08.133Additional details
Identifiers
- DOI
- 10.1016/j.apsusc.2014.08.133;
- PII
- S0169-4332(14)01911-4;
Publishing Information
- Journal Title
- Applied Surface Science
- Journal Volume
- 317
- Journal Page Range
- p. 914-922
- ISSN
- 0169-4332
- CODEN
- ASUSEE
INIS
- Country of Publication
- Netherlands
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 46112736
- Subject category
- S37: INORGANIC, ORGANIC, PHYSICAL AND ANALYTICAL CHEMISTRY; S75: CONDENSED MATTER PHYSICS, SUPERCONDUCTIVITY AND SUPERFLUIDITY;
- Descriptors DEI
- ABSORPTION SPECTROSCOPY; ANTIBIOTICS; AQUEOUS SOLUTIONS; CATALYSTS; DECOMPOSITION; ESCHERICHIA COLI; NANOPARTICLES; PARTICLE SIZE; PNEUMONIA; PSEUDOMONAS; REDUCING AGENTS; REDUCTION; SALMONELLA; SILVER; SILVER NITRATES; SODIUM; SODIUM HYDROXIDES; STAPHYLOCOCCUS; STREPTOCOCCUS; TRANSMISSION ELECTRON MICROSCOPY
- Descriptors DEC
- ALKALI METAL COMPOUNDS; ALKALI METALS; ANTI-INFECTIVE AGENTS; BACTERIA; CHEMICAL REACTIONS; DISEASES; DISPERSIONS; DRUGS; ELECTRON MICROSCOPY; ELEMENTS; HOMOGENEOUS MIXTURES; HYDROGEN COMPOUNDS; HYDROXIDES; METALS; MICROORGANISMS; MICROSCOPY; MIXTURES; NITRATES; NITROGEN COMPOUNDS; ORGANIC COMPOUNDS; OXYGEN COMPOUNDS; PARTICLES; RESPIRATORY SYSTEM DISEASES; SILVER COMPOUNDS; SIZE; SODIUM COMPOUNDS; SOLUTIONS; SPECTROSCOPY; TRANSITION ELEMENT COMPOUNDS; TRANSITION ELEMENTS
Optional Information
- Copyright
- Copyright (c) 2014 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.